Exelon: Regulatory Uncertainty and Limited Catalysts Support Hold Rating

Exelon, the Utilities sector company, was revisited by a Wall Street analyst today. Analyst James Thalacker from BMO Capital downgraded the rating on the stock to a Hold and gave it a $49.00 price target.

James Thalacker has given his Hold rating due to a combination of factors tied mainly to rising regulatory risk and limited valuation upside. He points out that recent developments in Pennsylvania, along with ongoing issues in Maryland and Illinois, have broadened regulatory uncertainty across key service territories that together account for a significant portion of Exelon’s regulated asset base.

Although he acknowledges management’s solid record in dealing with regulators and its confidence in delivering earnings growth near the high end of its 5–7% guidance through 2029, he sees little near‑term catalyst for a higher valuation multiple. In his view, the stock is likely to trade in a relatively tight range, as Exelon’s transmission‑and‑distribution‑focused profile and constrained flexibility for reallocating capital or accelerating growth projects limit the potential for meaningful outperformance versus peers.

In another report released today, Barclays also downgraded the stock to a Hold with a $49.00 price target.